Gabapentin and pregabalin inhibit the itch-associated response induced by the repeated application of oxazolone in mice

Journal of Pharmacological Sciences

Volumn 115, Issue 1, 2011, Pages 27-35

  Tsukumo, Yukihito ^a   Matsumoto, Yuichi ^a   Miura, Hiroko ^a   Yano, Hiroshi ^a   Manabe, Haruhiko ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Gabapentin; Oxazolone; Pregabalin; Pruritus

Indexed keywords

GABAPENTIN; OXAZOLONE; PREGABALIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CALCIUM CHANNEL ALPHA2 DELTA SUBUNIT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG REEXPOSURE; DRUG STRUCTURE; IC 50; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PRURITUS; RAT; SPINAL GANGLION; STEREOSPECIFICITY;

EID: 79952397013     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10173FP     Document Type: Article

References (48)

1. Hanifin JM. Pharmacophysiology of atopic dermatitis. Clin Rev Allergy. 1986;4:43-65.
2. Gilchrest BA. Pruritus: pathogenesis, therapy, and significance in systemic disease states. Arch Intern Med. 1982;142:101-105. (Pubitemid 12207611)
3. Kimura T, Miyazawa H. The 'butterfly' sign in patients with atopic dermatitis: evidence for the role of scratching in the development of skin manifestations. J Am Acad Dermatol. 1989;21: 579-580.
4. Wahlgren CF. Itch and atopic dermatitis: an overview. J Dermatol. 1999;26:770-779.
5. Koblenzer CS. Itching and the atopic skin. J Allergy Clin Immunol. 1999;104:S109-S113. (Pubitemid 29455073)
6. Munday J, Bloomfield R, Goldman M, Robey H, Kitowska GJ, Gwiezdziski Z, et al. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. Dermatology. 2002;205:40-45. (Pubitemid 36152960)
7. Klein PA, Clark RAF. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999;135:1522-1525.
8. Hägermark Ö, Wahlgren C-F. Itch in atopic dermatitis: the role of histamine and other mediaters and the failure of antihistamine therapy. Dermatol Ther. 1996;1:75-82. (Pubitemid 126818801)
9. Wahlgren C-F, Hägermark Ö, Bergstrom R. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol. 1990;122:545-551. (Pubitemid 20137375)
10. Kitagaki H, Fujisawa S, Watanabe K, Hayakawa K, Shiohara T. Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J Invest Dermatol. 1995;105:749-755. (Pubitemid 26006351)
11. Harada D, Takada C, Tsukumo Y, Takaba K, Manabe H. Analyses of a mouse model of the dermatitis caused by 2, 4, 6-trinitro-1-chlorobenzene (TNCB)-repeated application. J Dermatol Sci. 2005;37:159-167.
12. Tsukumo Y, Harada D, Manabe H. Pharmacological characterization of itch-associated response induced by repeated application of oxazolone in mice. J Pharmacol Sci. 2010;133:255-262.
13. Serpell MG; Neuropathic pain study group. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002;99:557-566.
14. Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003;60:1274-1283. (Pubitemid 36460982)
15. Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions. Curr Opin Anaesthesiol. 2007;20:456-472. (Pubitemid 47415136)
16. Pan HL, Eisenach JC, Chen SR. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther. 1999;288:1026-1030. (Pubitemid 29254139)
17. Chen SR, Xu Z, Pan HL. Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats. Anesthesiology. 2001;95:1473-1479. (Pubitemid 33126761)
18. Field MJ, Holloman EF, McCleary S, Hughes J, Singh L. Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther. 1997;282:1242-1246. (Pubitemid 27408300)
19. 2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007;73:137-150.
20. Errante LD, Petroff OA. Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure. 2003;12:300-306. (Pubitemid 36806076)
21. 2δ subunit of a calcium channel. J Biol Chem. 1996;271:5768-5776.
22. Belliotti TR, Capiris T, Ekhato IV, Kinsora JJ, Field MJ, Heffner TG, et al. Structure-activity relationships of pregabalin and analogues that target the α2δ protein. J Med Chem. 2005;48: 2294-2307. (Pubitemid 40516424)
23. Winhoven SM, Coulson IH, Bottomley WW. Brachioradial pruritus: response to treatment with gabapentin. Br J Dermatol. 2004;150:786-787. (Pubitemid 38586244)
24. Mendham JE. Gabapentin for the treatment of itching produced by burns and wound healing in children: a pilot study. Burns. 2004;30:851-853. (Pubitemid 39536055)
25. Gunal AI, Ozalp G, Yoldas TK, Gunal SY, Kirciman E, Celiker H. Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant. 2004;19:3137-3139. (Pubitemid 40063517)
26. Ständer S, Schmelz M. Chronic itch and pain-similarities and differences. Eur J Pain. 2006;10:473-478.
27. 3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol. 1993;244:293-301.
28. Kuraishi Y, Nagasawa T, Hayashi K, Sato M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur J Pharmacol. 1995;275:229-233.
29. Takasaki I, Andoh T, Nojima H, Shiraki K, Kuraishi Y. Gabapentin antinociception in mice with acute herpetic pain induced by herpes simplex virus infection. J Pharmacol Exp Ther. 2001;296: 270-275. (Pubitemid 32112450)
30. Taylor CP, Vartanian MG, Yuen PW, Bigge C, Suman-Chauhan N, Hill DR. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res. 1993;14:11-15. (Pubitemid 23030521)
31. Yoon MH, Yaksh TL. The effect of intrathecal gabapentin on pain behavior and hemodynamics on the formalin test in the rat. Anesth Analg. 1999;89:434-439. (Pubitemid 29367730)
32. Hwang JH, Yaksh TL. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth. 1997;22:249-256. (Pubitemid 27217143)
33. 2δ) subunit mRNA-containing cells in the rat central nervous system and the dorsal root ganglia. J Comp Neurol. 2005;491:246-269.
34. 2δ) type 1 protein. Neuroscience. 2008;155:510-521.
35. Hill DR, Suman-Chauhan N, Woodruff GN. Localization of [3H] gabapentin to a novel site in rat brain: autoradiographic studies. Eur J Pharmacol. 1993;244:303-309. (Pubitemid 23051253)
36. Ellis SB, Williams ME, Ways NR, Brenner R, Sharp AH, Leung AT, et al. Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel. Science. 1988;241:1661-1664.
37. 2δ subunit. J Neurosci. 1999;19:684-691.
38. 2δ auxiliary subunit gene (CACNA2D2). J Biol Chem. 2000; 275:12237-12242.
39. 2δ-4 subunit. Mol Pharmacol. 2002;62:485-496.
40. 2δ sub-units-structure and gabapentin binding. Mol Pharmacol. 2001; 59:1243-1248.
41. 2δ for gabapentin binding. Biochem J. 1999;342:313-320.
42. Field MJ, Cox PJ, Stott E, Melrose H, Offord J, Su TZ, et al. Identification of the α2δ1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci U S A. 2006;103: 17537-17542. (Pubitemid 44789004)
43. 2δ-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther. 2002;303: 1199-1205.
44. 2δ subunits of voltage-gated calcium channels. Trends Pharmacol Sci. 2007;28:220-228.
45. 2δ-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci. 2004;24: 8494-8499.
46. Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 2003;105:133-141. (Pubitemid 37162482)
47. Coderre TJ, Kumar N, Lefebvre CD, Yu JS. Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem. 2005;94:1131-1139. (Pubitemid 41170599)
48. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature. 2007;448:700-703.